Pentagon Mandates T-Tests—Doctors Push Back

Gloved hand holding a blood sample tube — Photo: Roman Zaiets / Shutterstock

The Pentagon has ordered annual testosterone screening for every service member age 30 and older, tying it directly to military readiness.

Story Highlights

A signed Defense memorandum makes testosterone screening a required part of the Periodic Health Assessment for troops 30 and older.
Defense officials link the policy to force readiness and human performance across the services.
Clinicians and medical groups question universal screening and warn about false positives and overtreatment risks.
The order does not mandate treatment; therapy remains a medical decision based on confirmed deficiency and symptoms.

What The New Order Requires Across The Force

Defense leaders issued a memorandum making testosterone screening mandatory for all Active Duty and Reserve personnel aged thirty and older as part of the annual Periodic Health Assessment. The directive takes effect immediately and applies across every service component. The document states that screening is required, not optional, within the standard assessment pipeline. Reporting lines run through existing readiness channels. The memorandum’s text is explicit and formal, leaving little room for uneven implementation across units or commands.

Pentagon spokesmen and coverage from national outlets report that the department frames the testing as part of a broader push to strengthen health and performance. Officials say the goal is to find and treat testosterone deficiency early, which they argue can support readiness. The public messaging links the screening to the military’s duty cycle and the need for peak output in training and deployments. Several major outlets summarized the plan and the age threshold for the annual test.

How Screening Would Work For Service Members

The screening occurs during the Periodic Health Assessment that every service member completes each year. Medical teams collect labs and review symptoms as part of the visit. The order adds a testosterone check for those thirty and older, but it does not force treatment. Doctors still make care choices based on clinical standards. The policy’s structure builds on an existing annual process used to track individual medical readiness and fit it into the chain’s health records.

Medical experts note that testosterone tests can vary based on time of day, recent meals, and stress. Low values often require a second morning test to confirm. Clinicians warn that broad screening can pull in many borderline results. That can trigger more testing and referrals without clear proof of a benefit for healthy, symptom-free troops. Specialty guidelines have long favored testing based on symptoms and risk factors rather than mass screening.

Supporters Say Readiness; Doctors Urge Caution

Defense leaders argue that finding true hormone deficiency earlier could improve energy, resilience, and recovery. They stress that the policy focuses on health, not artificial enhancement. The department’s message places this step within a larger effort to cut preventable downtime and sharpen performance under load. Coverage shows the Pentagon linking the move to modern force upkeep and to a culture of accountability for health standards across the ranks.

Reuters reported that a majority of outside physicians they contacted questioned universal screening and its readiness payoff. Doctors cited guideline statements that recommend against population screening in men without symptoms and warned about unnecessary or even harmful treatment. Reuters also noted that the order does not mandate therapy; treatment decisions remain clinical. The core critique is evidence strength: experts want proof that blanket testing helps outcomes in a healthy, working-age force.

Costs, Risks, And Guardrails The Force Should Expect

CBS News quoted clinicians who said routine testing has not been shown to make healthy troops better soldiers. They flagged cost concerns, false positives, and logistics, since tests should be done in the morning and confirmed. They pointed to guidance from the Endocrine Society and the American College of Physicians that argues against general screening. These groups recommend treatment only for men with confirmed deficiency and relevant symptoms, such as low libido, fatigue, or reduced muscle mass.

U.S. Medicine reported that the Endocrine Society restated that evidence does not support population-level screening of asymptomatic men. A urologist told the outlet the policy is not sound strategy if it pushes treatment in the absence of symptoms and careful diagnosis. Taken together, these concerns urge tight guardrails: correct timing for tests, confirmatory labs, symptom checks, and clear communication that no one is forced into therapy. Those steps reduce overdiagnosis and protect readiness goals.

Bottom Line For Troops And Commanders

The order is real, immediate, and force-wide. Every service member age thirty and older will get tested during the Periodic Health Assessment, and no one is automatically placed on therapy. Commanders should set expectations early, protect privacy, and avoid any hint of coercion based on lab numbers alone. Medical teams should follow clinical guidelines on confirmatory testing and symptom review. That approach balances the department’s readiness aims with the duty to avoid waste, overreach, and unintended harm.